MX2010004876A - Derivados de diamido tiazol como inhibidores de la proteina cinasa. - Google Patents
Derivados de diamido tiazol como inhibidores de la proteina cinasa.Info
- Publication number
- MX2010004876A MX2010004876A MX2010004876A MX2010004876A MX2010004876A MX 2010004876 A MX2010004876 A MX 2010004876A MX 2010004876 A MX2010004876 A MX 2010004876A MX 2010004876 A MX2010004876 A MX 2010004876A MX 2010004876 A MX2010004876 A MX 2010004876A
- Authority
- MX
- Mexico
- Prior art keywords
- diamido
- thiazole derivatives
- protein kinase
- kinase inhibitors
- disorder
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
La presente invención se relaciona derivados de diamidotiazol novedosos de estructura I, composiciones que comprenden los derivados de diamidotiazol y métodos para usar los derivados de diamidotiazol para tratar o prevenir un trastorno proliferativo, un trastorno antiproliferativo, inflamación, artritis, un trastorno del sistema nervioso central, una enfermedad cardiovascular, alopecia, una enfermedad neuronal, una lesión isquémica, una infección viral, una infección fúngica o un trastorno relacionado con la actividad de una proteína quinasa; formula (I) en donde: M es -C(O)-, -C(S)-. - S(O)-. -S(O)2-. -NHS(O)2-. -OC(O)- o -NHC(O)-; Q es la fórmula (II).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98334107P | 2007-10-29 | 2007-10-29 | |
PCT/US2008/081319 WO2009058730A1 (en) | 2007-10-29 | 2008-10-27 | Diamido thiazole derivatives as protein kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004876A true MX2010004876A (es) | 2010-07-28 |
Family
ID=40251766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004876A MX2010004876A (es) | 2007-10-29 | 2008-10-27 | Derivados de diamido tiazol como inhibidores de la proteina cinasa. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2217595A1 (es) |
JP (1) | JP2011502158A (es) |
CN (1) | CN101910164A (es) |
CA (1) | CA2703980A1 (es) |
MX (1) | MX2010004876A (es) |
WO (1) | WO2009058730A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2703978A1 (en) * | 2007-10-29 | 2009-05-07 | Schering Corporation | Thiazole derivatives as protein kinase inhibitors |
US8435976B2 (en) | 2009-09-08 | 2013-05-07 | F. Hoffmann-La Roche | 4-substituted pyridin-3-yl-carboxamide compounds and methods of use |
ES2557316T3 (es) * | 2009-09-08 | 2016-01-25 | F. Hoffmann-La Roche Ag | Compuestos de piridín-3-il-carboxamida 4-sustituidos y métodos de utilización |
MX2012011533A (es) * | 2010-04-07 | 2012-12-17 | Hoffmann La Roche | Compuestos de pirazol-4-il-heterociclil-carboxamida y metodos de uso. |
NZ604306A (en) | 2010-05-17 | 2015-02-27 | Incozen Therapeutics Pvt Ltd | Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases |
US9815831B2 (en) | 2012-03-30 | 2017-11-14 | Rhizen Pharmaceuticals Sa | 3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases |
CA2920791C (en) | 2013-10-14 | 2021-11-16 | Eisai R&D Management Co., Ltd. | Selectively substituted quinoline compounds |
PE20160608A1 (es) | 2013-10-14 | 2016-07-08 | Eisai Randd Man Co Ltd | Compuestos de quinolina selectivamente sustituida |
BR112020014561A2 (pt) | 2018-01-17 | 2020-12-08 | Migal - Galilee Research Institute Ltd. | Nibidores inovadores da via metabólica da metionina |
EP3740482A1 (en) | 2018-01-17 | 2020-11-25 | Migal Galilee Research Institute Ltd. | New methionine metabolic pathway inhibitors |
CN110412004A (zh) * | 2019-08-29 | 2019-11-05 | 苏州新格诺康生物技术有限公司 | 一种去泛素化酶的活性检测方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI372050B (en) * | 2003-07-03 | 2012-09-11 | Astex Therapeutics Ltd | (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles |
US8163746B2 (en) * | 2006-04-19 | 2012-04-24 | Astellas Pharma Inc. | Azolecarboxamide derivative |
KR20090075869A (ko) * | 2006-10-31 | 2009-07-09 | 쉐링 코포레이션 | 단백질 키나제 억제제로서의 2-아미노티아졸-4-카복실산 아미드 |
-
2008
- 2008-10-27 CA CA2703980A patent/CA2703980A1/en not_active Abandoned
- 2008-10-27 MX MX2010004876A patent/MX2010004876A/es not_active Application Discontinuation
- 2008-10-27 WO PCT/US2008/081319 patent/WO2009058730A1/en active Application Filing
- 2008-10-27 CN CN2008801234697A patent/CN101910164A/zh active Pending
- 2008-10-27 EP EP08843554A patent/EP2217595A1/en not_active Withdrawn
- 2008-10-27 JP JP2010532173A patent/JP2011502158A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2217595A1 (en) | 2010-08-18 |
JP2011502158A (ja) | 2011-01-20 |
CN101910164A (zh) | 2010-12-08 |
CA2703980A1 (en) | 2009-05-07 |
WO2009058730A1 (en) | 2009-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010004876A (es) | Derivados de diamido tiazol como inhibidores de la proteina cinasa. | |
MX2009004791A (es) | Derivados de anilinopiperazina t metodos de uso de los mismos. | |
MX2009004785A (es) | Amidas 2-aminotiazol-4-carboxilicas como inhibidores de proteina quinasa. | |
MX2009004786A (es) | Derivados de anilinopiperazina y sus metodos de uso. | |
MX2010004875A (es) | Derivados de tiazol y metodos para utilizarlos. | |
WO2011025706A3 (en) | Heterocyclic amide compounds as protein kinase inhibitors | |
MX2010004880A (es) | Derivados heterociclicos de urea y tiourea, y metodos de uso de los mismos. | |
MX2008012422A (es) | Derivados de furano y tiofeno, pirrol substituido con pirimidinil y piridil como inhibidores de cinasa. | |
CY1116754T1 (el) | Παραγωγα νιτροκατεχολης ως αναστολεις της comt | |
HK1135103A1 (en) | Dihydropyridine derivatives useful as protein kinase inhibitors | |
EA201170249A1 (ru) | 3,4-диарилпиразолы в качестве ингибиторов протеинкиназ | |
WO2009011850A3 (en) | Novel therapeutic compounds | |
GEP20105054B (en) | Imidazoquinolines as lipid kinase inhibitors | |
MY150032A (en) | Heterocyclic amide compounds as protein kinase inhibitors | |
GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
MX2010004878A (es) | Derivados de tioeter y eter heterociclico y metodos de uso de los mismos. | |
NO20083427L (no) | Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse | |
DK2105164T3 (da) | Nye P2X7R-antagonister og deres anvendelse | |
EA200701808A1 (ru) | Производные тетрагидроиндолона и тетрагидроиндазолона | |
EA200900983A1 (ru) | Соединения и композиции в качестве ингибиторов киназы | |
ATE514699T1 (de) | Substituierte pyrrolopyrazolderivate als kinaseinhibitoren | |
WO2007076161A3 (en) | Compounds with therapeutic activity | |
MX2009010083A (es) | Compuestos biarilo y biheteroarilo de utilidad en el tratamiento de trastornos de hierro. | |
GEP201706707B (en) | 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes | |
PH12014502541A1 (en) | 5-amino [1,4] thiazines as bace 1 inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |